Litcius/Paper detail

Mitomycin Gel (UGN-101) as a Kidney-sparing Treatment for Upper Tract Urothelial Carcinoma in Patients with Imperative Indications and High-grade Disease

Kyle Rose, Katie S. Murray, Craig Labbate, Solomon L. Woldu, Jennifer Linehan, Joseph Jacob, Hristos Z. Kaimakliotis, Rian Dickstein, Adam S. Feldman, Surena F. Matin, Yair Lotan, Mitchell R. Humphreys, Wade J. Sexton

2023European Urology Focus14 citationsDOIOpen Access PDF

Topics & Concepts

MedicineUrothelial carcinomaMitomycin CDiseaseUrologyUrothelial cancerKidney diseaseCarcinomaInternal medicineOncologySurgeryCancerBladder cancerBladder and Urothelial Cancer TreatmentsRenal cell carcinoma treatmentEsophageal Cancer Research and Treatment
Mitomycin Gel (UGN-101) as a Kidney-sparing Treatment for Upper Tract Urothelial Carcinoma in Patients with Imperative Indications and High-grade Disease | Litcius